Parkwood LLC’s Prelude Therapeutics PRLD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,667	Closed	-$158K	–	145
2021 Q4	$158K	Buy	+12,667	New	+$158K	0.03%	111
2021 Q2	–	Sell	-5,037	Closed	-$218K	–	125
2021 Q1	$218K	Buy	+5,037	New	+$218K	0.04%	105